Workflow
Corteva(CTVA)
icon
Search documents
Is Corteva Stock Underperforming the Nasdaq?
Yahoo Finance· 2026-03-10 14:21
Company Overview - Corteva, Inc. (CTVA) has a market capitalization of $52.7 billion and operates in the agriculture sector, providing services across various global markets including North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa [1] - The company has two main segments: Seed and Crop Protection, focusing on advanced seed genetics, traits, and crop protection products to enhance farm productivity and resilience [1][2] Stock Performance - Corteva's shares have decreased by 3.9% from their 52-week high of $80.90, but have increased by 18.6% over the past three months, outperforming the Nasdaq Composite, which declined by 4% during the same period [3] - Year-to-date, CTVA stock is up 15.1%, while the Nasdaq Composite has dropped by 2.3%. Over the past 52 weeks, the stock has returned 28.1%, lagging behind the Nasdaq's 30% return [6] Financial Results - Following the Q4 2025 results, Corteva's shares rose slightly as the adjusted EPS of $0.22 met Wall Street expectations. The company reported a full-year income of $1.20 billion ($1.75 per share) on sales of $17.40 billion, with operating cash flow increasing by 51% to $3.5 billion and free cash flow rising by 69% to $2.9 billion [7] - Management has provided a 2026 outlook of $4 billion to $4.2 billion in operating EBITDA and $3.45 to $3.70 in operating EPS, despite quarterly revenue of $3.91 billion falling short of consensus estimates [8] Analyst Sentiment - Analysts maintain a moderately optimistic outlook for CTVA stock, with a consensus rating of "Moderate Buy" from 22 analysts. The mean price target is set at $83.35, indicating a potential upside of 7.3% from current levels [9]
Corteva to Webcast Investor Days for Two New Companies
Prnewswire· 2026-03-09 12:00
Core Insights - Corteva will host a live video webcast for its Investor Day on September 15, 2026, focusing on the introduction of its seed and genetics business ("SpinCo") and the future vision of the crop protection business ("New Corteva") [1] Group 1: Investor Day Details - The Investor Day will be divided into two parts: the first part at 9:00 AM EDT will introduce SpinCo, while the second part at 1:00 PM EDT will present New Corteva's vision post-separation [1] - Management presentations and a Q&A session will be included in both parts of the Investor Day [1] - Registration for the webcasts will be available on Corteva's Investor Events and Presentations page, with materials and replays accessible until September 15, 2027 [1] Group 2: About New Corteva - New Corteva is positioned as a global leader in crop protection, offering a comprehensive portfolio of innovative and sustainable solutions, including a rapidly growing biologicals platform [1] - The company aims to leverage its operational excellence, supply chain optimization, and regulatory expertise to assist farmers in protecting yields and enhancing returns [1] Group 3: About SpinCo - SpinCo, Corteva's seed and genetics business, focuses on advanced genetics and employs cutting-edge breeding technologies to achieve higher yields, improved sustainability, and stronger crop health [1] - SpinCo is built on a century-long legacy of innovation and customer loyalty through the Pioneer® brand, combining strong market leadership and financial strength with a direct-to-farmer business model [1]
Farm Software Management Solution Market Size to Grow USD 5.37 Billion by 2035 | Research by SNS Insider
Globenewswire· 2026-03-09 03:30
Market Overview - The Farm Software Management Solution Market was valued at USD 2.41 billion in 2025 and is projected to reach USD 5.37 billion by 2035, with a CAGR of 8.37% from 2026 to 2035 [1][5]. Government and Regulatory Influence - Government mandates such as USDA digital agriculture requirements and EU Farm-to-Fork strategy compliance are significant drivers for market expansion, enhancing farm data accessibility and agricultural transparency [1]. Market Segmentation By Component - The software segment accounted for approximately 67.45% of revenue in 2025, driven by demand for integrated farm management platforms, while the services segment is expected to grow at a CAGR of nearly 9.12% from 2026 to 2035 [6]. By Deployment Mode - The cloud-based segment contributed 61.38% of revenue in 2025, favored for its scalability and cost-effectiveness, while on-premises solutions remain important for large agribusinesses due to localized data needs [7]. By Farm Size - Large farms held about 48.73% of the market share, with medium farms expected to grow at a CAGR of around 9.04% during the forecast period as they seek comprehensive management platforms [8]. By Application - Crop management applications represented approximately 32.56% of revenue in 2025, with livestock management anticipated to grow at a CAGR of about 8.89% from 2026 to 2035 [10]. By End-User - Farmers comprised 52.61% of the market share, while agribusinesses are projected to grow at a CAGR of around 9.23% during the forecast period [11]. Regional Insights - The Asia Pacific region is the fastest-growing segment with a CAGR of 10.14%, driven by increasing awareness of digital agricultural services and government initiatives [12]. - North America held over 38.42% of the market share in 2025, supported by a robust agri-tech environment and stringent data record-keeping requirements [13]. Key Players - Leading market players include Trimble Inc., Deere & Company, CNH Industrial, AGCO Corporation, and Climate Corporation among others [4]. Recent Developments - Trimble Inc. expanded its software platform with AI capabilities in March 2025, while Deere & Company launched an enhanced cloud-based platform in January 2025, both aimed at improving farm productivity and digital management adoption [16].
Ascribe Announces Collaboration with Corteva to Advance Seed Treatment Use for Phytalix® Biofungicide
Businesswire· 2026-03-05 13:05
Core Insights - Ascribe Bio and Corteva have announced a research and development collaboration aimed at advancing novel biofungicide seed treatments [1] Company Collaboration - The partnership between Ascribe Bio and Corteva focuses on the development of innovative biofungicide solutions for seed treatments, indicating a strategic move towards sustainable agricultural practices [1]
Corteva Announces Dates for First Quarter 2026 Earnings Release and Webcast
Prnewswire· 2026-03-05 13:00
Core Viewpoint - Corteva, Inc. will release its first quarter 2026 earnings on May 5, 2026, after market close, with a live webcast presentation scheduled for May 6, 2026, at 9:00 a.m. Eastern Time [1] Group 1: Earnings Release Information - The earnings release will be made available via press release and the company's website [1] - A slide presentation accompanying the webcast will be posted on the Investor Events and Presentations page [1] - A replay of the webcast will be accessible until May 6, 2027 [1] Group 2: Company Overview - Corteva, Inc. is a global pure-play agriculture company focused on delivering solutions for significant agricultural challenges [1] - The company utilizes a unique distribution strategy and offers a balanced mix of seed, crop protection, and digital products and services [1] - Corteva is committed to maximizing productivity for farmers and ensuring progress for future generations [1]
Corteva targets fourth quarter for planned split into two companies
Reuters· 2026-02-25 16:26
Corteva targets fourth quarter for planned split into two companies | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]The logo and trading info for Corteva Agriscience, a former division of DowDuPont, is displayed on a screen at the New York Stock Exchange (NYSE) in New York, U.S., June 3, 2019.... [Purchase Licensing Rights, opens new tab] Read moreFeb 25 (Reuters) - U.S. agrichemicals company Corteva [(CTVA.N), opens new tab] said ...
Corteva, Inc. (CTVA) Presents at Bank of America 2026 Global Agriculture and Materials Conference Transcript
Seeking Alpha· 2026-02-25 16:17
Core Insights - Corteva experienced strong growth in both top and bottom lines in 2025, with better-than-expected cash generation, and anticipates continued growth in 2026 [2] Business Performance - The growth for Corteva is primarily driven by organic growth within its growth platform, particularly through its out-licensing strategy in the Seed segment, which is expected to create significant long-term value for shareholders [2]
Corteva (NYSE:CTVA) 2026 Conference Transcript
2026-02-25 15:02
Corteva 2026 Conference Call Summary Company Overview - **Company**: Corteva (NYSE:CTVA) - **Date**: February 25, 2026 - **Key Speakers**: Chuck Magro (CEO), David Johnson (CFO) Core Industry Insights - **Industry**: Agriculture, specifically focusing on seed and crop protection (CP) sectors - **Market Dynamics**: The demand for crop protection is expected to grow, driven by environmental pressures and the need for farmers to protect their crops effectively [27][30]. Financial Performance - **2025 Performance**: - EBITDA reached **$3.85 billion**, a **14% increase** from the previous year [13]. - EBITDA margins improved by **215 basis points**, reaching **22.1%** [13][14]. - Free cash flow was **$2.9 billion**, with over **75%** of EBITDA converted to free cash flow [14]. - **$1.5 billion** was returned to shareholders through buybacks and dividends [14]. - **2026 Projections**: - Expected **7% increase** in EBITDA, with both seed and CP businesses anticipated to grow [15]. - Net royalty position expected to be neutral, two years ahead of previous forecasts [15]. Strategic Initiatives - **Separation Plan**: Corteva plans to separate into two independent companies focused on crop protection and advanced genetics, with the separation expected in the **fourth quarter of 2026** [5][6]. - **Cost Synergies**: Anticipated dis-synergies of approximately **$100 million** annually, with **$50 million** included in the 2026 guidance [5][6][89]. Growth Platforms - **Seed Business**: - Out-licensing strategy aimed at capturing value through differentiated technology, with a goal for biologicals to reach **$1 billion** in the future [4]. - New products in the CP sector projected to generate over **$2 billion** in revenue within the next couple of years [4]. - **Technological Investment**: Corteva invests nearly **$1 billion** annually in seed technology, emphasizing the continuous improvement of seed performance [22]. Market Trends and Challenges - **Competitive Landscape**: The CP industry is currently at a cyclical trough, with expectations for growth driven by volume rather than price [30][35]. - **China's Role**: Concerns about commoditization from Chinese competitors are acknowledged, but differentiation in technology remains critical for maintaining market position [34][35]. - **Regulatory and Environmental Factors**: The company is adapting to regulatory changes and environmental pressures, which are influencing product development and market strategies [30][35]. Future Outlook - **Hybrid Wheat Development**: Corteva is excited about the potential of hybrid wheat, projecting a **billion-dollar revenue opportunity** in the next decade, with a launch planned for **2027** in the U.S. [78][80]. - **AI Integration**: The use of AI in R&D is transforming the discovery process, significantly speeding up the identification of active ingredients and improving regulatory submission efficiency [94][96]. Conclusion Corteva is positioned for continued growth in the agricultural sector, with a strong focus on innovation, strategic separation, and market adaptability. The company aims to leverage its technological advancements and market leadership to enhance shareholder value and address the evolving needs of farmers globally.
Corteva(CTVA) - 2025 Q4 - Annual Report
2026-02-12 22:24
Business Operations - Corteva operates in approximately 110 countries, providing a broad portfolio of agriculture solutions to enhance farmer productivity[27]. - The company plans to separate its Seed and Crop Protection segments into two standalone, publicly traded companies by October 1, 2025[29]. - Corteva's supply chain strategy emphasizes managing global supplies of active ingredients with a flexible global footprint to support future growth[46]. - The company leverages a multi-channel distribution strategy, including direct sales to farmers, regional seed brands, and retail channels[38]. - Corteva operates 95 production sites globally, with 61 dedicated to Seed and 34 to Crop Protection[178]. - The company has 38 production sites in North America, 12 in EMEA, 8 in Latin America, and 3 in Asia Pacific[178]. Financial Performance - The company reported net sales of $17,401 million for the year ended December 31, 2025, a 3% increase compared to 2024, driven by a 1% increase in price and a 3% increase in volume[211]. - Cost of goods sold (COGS) decreased to $9,172 million from $9,529 million in 2024, attributed to ongoing cost and productivity actions, raw material deflation, and lower commodity prices[211]. - Income from continuing operations after income taxes was $1,204 million, up from $863 million in 2024[211]. - Operating EBITDA increased to $3,848 million from $3,376 million in 2024, primarily due to volume growth and favorable product mix[211]. - The company returned approximately $1.5 billion to shareholders in 2025 through share repurchase programs and dividends[211]. - The quarterly common stock dividend was increased by approximately 6% from $0.17 to $0.18 per share[211]. - The company experienced a 2% decrease in net sales from 2023 to 2024, with net sales of $16,908 million in 2024 compared to $17,226 million in 2023, primarily due to a 1% decrease in price and a 3% unfavorable currency impact[222][225]. Research and Development - Corteva's investments in R&D focus on customer-driven innovation to enhance seed quality and respond to changing customer needs[40]. - Research and development (R&D) expenses increased to $1,474 million (8% of net sales) in 2025 from $1,402 million (8% of net sales) in 2024, reflecting higher employee compensation and contractor costs[229][230]. - Corteva owns about 5,900 U.S. patents and approximately 10,200 active patents outside of the U.S. as of December 31, 2025[58]. - The company has approximately 3,400 patent applications pending as of December 31, 2025[59]. - Corteva's intellectual property estate, including patents and trade secrets, is considered a valuable asset that provides a competitive advantage[56]. Market Challenges - The company faces intense competition from key players like BASF, Bayer, and Syngenta in the global agriculture market[62]. - Input costs, including raw materials and production costs, are variable and can significantly impact Corteva's financial results[104]. - Changes in agricultural policies and government subsidies may inhibit market growth for Corteva's products, affecting growers' purchasing power[87]. - Public acceptance of Corteva's biotechnology products can affect sales and operations, with growing societal demands for product safety and environmental protection potentially leading to regulatory challenges[84]. - Regulatory scrutiny may increase as Corteva's business grows, potentially resulting in fines, penalties, or restrictions that could significantly impact operations[86]. Risk Management - The company actively manages risks associated with supply chain disruptions, cybersecurity threats, and industrial espionage, which could adversely affect its operations[109]. - Corteva anticipates that future pandemics or epidemics could disrupt its global supply chain and operations, impacting its financial condition and results[136]. - The company relies on third parties for raw materials and commercialization, and disruptions in these relationships could delay product development and commercialization[123]. - Corteva's ability to raise capital through the capital markets or short-term debt borrowings could be impaired, negatively affecting its liquidity[128]. - The prevalence of counterfeit products poses significant risks to Corteva's reputation and consumer trust, potentially leading to lost sales[145]. Corporate Governance - Corteva's management team averages about 20 years of experience in agriculture, supporting the execution of its strategy and product pipelines[55]. - The company has implemented safety programs to promote a culture of safety, with no work stoppages due to strikes or lockouts reported in 2025[51][52]. - Corteva maintains nine global employee business resource groups to foster an inclusive work environment[53]. - The Audit Committee conducts a minimum of two cybersecurity program updates per year, reviewing capital spend and staffing[175]. - Corteva's Chief Information Officer and Chief Information Security Officer regularly report on cybersecurity risks to the Board[177]. Strategic Initiatives - The Crop Protection Operations Strategy Restructuring Program is expected to achieve $180 million in savings on a run rate basis by 2027[215]. - The company recorded net pre-tax restructuring and asset-related charges of $611 million under the Crop Protection Operations Strategy Restructuring Program[213]. - Cash payments related to restructuring charges are anticipated to be between $330 million and $360 million, with $177 million paid through December 31, 2025[214]. - The proposed separation of Corteva's Seed and Crop Protection businesses is intended to be a tax-free spin-off, but it is subject to customary conditions and risks[161]. - Corteva is evaluating acquisition candidates and strategic investments, with potential risks associated with integration and achieving expected financial results[127].
科迪华分拆计划获批,聚焦作物保护与种子业务
Jing Ji Guan Cha Wang· 2026-02-12 14:11
Company Developments - Corteva's board approved a plan to split the company into two independent publicly traded entities, expected to be completed in the second half of 2026. "New Corteva" will focus on crop protection (including biopesticides), while "SpinCo" will concentrate on seeds and emerging technologies such as gene editing and biofuels [2] Product Development Progress - The company plans to launch the biostimulant seed treatment Lumidapt Valta LS in the U.S. market for the 2026 planting season, which has completed the regulatory approval phase and aims to enhance crop yields [3] Performance Strategy - Corteva provided preliminary performance outlook for 2026, expecting a midpoint of $4.18 billion in earnings before interest, taxes, depreciation, and amortization (EBITDA), reflecting the company's confidence in its growth potential [4] Strategic Initiatives - Corteva has established a multi-year collaboration with Profluent Bio to leverage AI technologies, such as the OpenCRISPR-1 genome editing tool, to accelerate the development of resilient and high-yield crop varieties, which may drive long-term innovation [5]